{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:53:25Z","timestamp":1790679205594,"version":"4.1.0"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.biochi.2016.09.011","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T03:22:57Z","timestamp":1474428177000},"page":"152-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Alterations in membrane trafficking and pathophysiological implications in lysosomal storage disorders"],"prefix":"10.1016","volume":"130","author":[{"given":"Eva-Maria","family":"Kuech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Brogden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4884-8425","authenticated-orcid":false,"given":"Hassan Y.","family":"Naim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2016.09.011_bib1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jpeds.2004.01.049","article-title":"Lysosomal storage disorders: the need for better pediatric recognition and comprehensive care","volume":"144","author":"Wilcox","year":"2004","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.biochi.2016.09.011_bib2","series-title":"Fabry Disease: Perspectives from 5 Years of FOS","author":"Fuller","year":"2006"},{"key":"10.1016\/j.biochi.2016.09.011_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/adc.2009.173419","article-title":"The epidemiology of progressive intellectual and neurological deterioration in childhood","volume":"95","author":"Verity","year":"2010","journal-title":"Archives Dis. Child."},{"key":"10.1016\/j.biochi.2016.09.011_bib4","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbamcr.2008.12.001","article-title":"Lysosomal disorders: from storage to cellular damage","volume":"1793","author":"Ballabio","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biochi.2016.09.011_bib5","first-page":"102","article-title":"Lysosomal storage disease: revealing lysosomal function and physiology","volume":"25","author":"Parkinson-Lawrence","year":"2010","journal-title":"Physiol. (Bethesda, Md.)"},{"key":"10.1016\/j.biochi.2016.09.011_bib6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1083\/jcb.201208152","article-title":"The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction","volume":"199","author":"Platt","year":"2012","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.biochi.2016.09.011_bib7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/1615-9861(200208)2:8<1026::AID-PROT1026>3.0.CO;2-I","article-title":"Proteomic analysis of human lysosomes: application to monocytic and breast cancer cells","volume":"2","author":"Journet","year":"2002","journal-title":"Proteomics"},{"key":"10.1016\/j.biochi.2016.09.011_bib8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrm1423","article-title":"The cell biology of lysosomal storage disorders","volume":"5","author":"Futerman","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biochi.2016.09.011_bib9","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35022604","article-title":"Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)","volume":"406","author":"Nishino","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2016.09.011_bib10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1203\/00006450-199606000-00022","article-title":"Cathepsin A deficiency in galactosialidosis: studies of patients and carriers in 16 families","volume":"39","author":"Kleijer","year":"1996","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.biochi.2016.09.011_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0092-8674(03)00347-7","article-title":"Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme","volume":"113","author":"Dierks","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.biochi.2016.09.011_bib12","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1093\/hmg\/ddv457","article-title":"Gene therapy for lysosomal storage disorders: a good start","volume":"25","author":"Biffi","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biochi.2016.09.011_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10545-010-9075-9","article-title":"Pathophysiology of neuropathic lysosomal storage disorders","volume":"33","author":"Bellettato","year":"2010","journal-title":"J.\u00a0Inherit. Metabolic Dis."},{"key":"10.1016\/j.biochi.2016.09.011_bib14","first-page":"112","article-title":"Membrane lipids: where they are and how they behave, Nature reviews","volume":"9","author":"van Meer","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biochi.2016.09.011_bib15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.vetmic.2015.05.024","article-title":"Cholesterol-rich lipid rafts play an important role in the Cyprinid herpesvirus 3 replication cycle","volume":"179","author":"Brogden","year":"2015","journal-title":"Veterinary Microbiol."},{"key":"10.1016\/j.biochi.2016.09.011_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2500\/ajra.2010.24.3444","article-title":"Antimicrobial lipids: novel innate defense molecules are elevated in sinus secretions of patients with chronic rhinosinusitis","volume":"24","author":"Lee","year":"2010","journal-title":"Am. J. Rhinol. Allergy"},{"key":"10.1016\/j.biochi.2016.09.011_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejcb.2014.07.005","article-title":"Lipid alterations in human blood-derived neutrophils lead to formation of neutrophil extracellular traps","volume":"93","author":"Neumann","year":"2014","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.biochi.2016.09.011_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/35036052","article-title":"Lipid rafts and signal transduction","volume":"1","author":"Simons","year":"2000","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biochi.2016.09.011_bib19","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbamem.2013.07.018","article-title":"Interaction of membrane\/lipid rafts with the cytoskeleton: impact on signaling and function: membrane\/lipid rafts, mediators of cytoskeletal arrangement and cell signaling","volume":"1838","author":"Head","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biochi.2016.09.011_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","article-title":"An overview of sphingolipid metabolism: from synthesis to breakdown","volume":"688","author":"Gault","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biochi.2016.09.011_bib21","doi-asserted-by":"crossref","first-page":"27494","DOI":"10.1016\/S0021-9258(18)47012-3","article-title":"A\u00a0unique mitochondria-associated membrane fraction from rat liver has a high capacity for lipid synthesis and contains pre-Golgi secretory proteins including nascent lipoproteins","volume":"269","author":"Rusinol","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.09.011_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-2275(20)40202-0","article-title":"The fatty acid composition of brain sphingolipids: sphingomyelin, ceramide, cerebroside, and cerebroside sulfate","volume":"5","author":"O'Brien","year":"1964","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.biochi.2016.09.011_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0009-3084(99)00071-7","article-title":"Sphingomyelin-cholesterol interactions in biological and model membranes","volume":"102","author":"Slotte","year":"1999","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.biochi.2016.09.011_bib24","doi-asserted-by":"crossref","first-page":"8247","DOI":"10.1073\/pnas.82.23.8247","article-title":"A\u00a0defect in cholesterol esterification in Niemann-Pick disease (type C) patients","volume":"82","author":"Pentchev","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2016.09.011_bib25","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cmet.2008.10.008","article-title":"Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance","volume":"8","author":"Radhakrishnan","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.biochi.2016.09.011_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.biochi.2016.09.011_bib27","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1194\/jlr.R047837","article-title":"Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin","volume":"55","author":"Vance","year":"2014","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.biochi.2016.09.011_bib28","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1126\/science.175.4023.720","article-title":"Fluid mosaic model of structure of cell-membranes","volume":"175","author":"Singer","year":"1972","journal-title":"Sci. (New York, N.Y.)"},{"key":"10.1016\/j.biochi.2016.09.011_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.biophys.32.110601.141803","article-title":"Model systems, lipid rafts, and cell membranes","volume":"33","author":"Simons","year":"2004","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/j.biochi.2016.09.011_bib30","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1021\/cn3000845","article-title":"Visualization of lipid raft membrane compartmentalization in living RN46A neuronal cells using single quantum dot tracking","volume":"3","author":"Chang","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biochi.2016.09.011_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.chembiol.2013.11.009","article-title":"Fluorescent probes for lipid rafts: from model membranes to living cells","volume":"21","author":"Klymchenko","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biochi.2016.09.011_bib32","doi-asserted-by":"crossref","first-page":"8500","DOI":"10.1073\/pnas.1404582111","article-title":"Membrane raft association is a determinant of plasma membrane localization","volume":"111","author":"Diaz-Rohrer","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2016.09.011_bib33","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1194\/jlr.M800092-JLR200","article-title":"Lipid composition of microdomains is altered in a cell model of Gaucher disease","volume":"49","author":"Hein","year":"2008","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.biochi.2016.09.011_bib34","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.cell.2009.03.049","article-title":"Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol","volume":"137","author":"Kwon","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.biochi.2016.09.011_bib35","doi-asserted-by":"crossref","first-page":"15287","DOI":"10.1073\/pnas.0807328105","article-title":"NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes","volume":"105","author":"Infante","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2016.09.011_bib36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cmet.2010.05.016","article-title":"Identification of surface residues on Niemann-Pick C2 essential for hydrophobic handoff of cholesterol to NPC1 in lysosomes","volume":"12","author":"Wang","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.biochi.2016.09.011_bib37","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbamcr.2008.10.016","article-title":"Sorting of lysosomal proteins","volume":"1793","author":"Braulke","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biochi.2016.09.011_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI112262","article-title":"Trafficking of lysosomal enzymes in normal and disease states","volume":"77","author":"Kornfeld","year":"1986","journal-title":"J.\u00a0Clin. investigation"},{"key":"10.1016\/j.biochi.2016.09.011_bib39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/bs.ircmb.2015.07.008","article-title":"Different pathways to the lysosome: sorting out alternatives","volume":"320","author":"Hasanagic","year":"2015","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.biochi.2016.09.011_bib40","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1126\/science.291.5512.2364","article-title":"Intracellular functions of N-linked glycans","volume":"291","author":"Helenius","year":"2001","journal-title":"Sci. (New York, N.Y.)"},{"key":"10.1016\/j.biochi.2016.09.011_bib41","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1242\/jcs.03225","article-title":"N-glycan processing in ER quality control","volume":"119","author":"Ruddock","year":"2006","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.biochi.2016.09.011_bib42","series-title":"Essentials of Glycobiology","article-title":"O-GalNAc glycans","author":"Brockhausen","year":"2009"},{"key":"10.1016\/j.biochi.2016.09.011_bib43","doi-asserted-by":"crossref","first-page":"10683","DOI":"10.1074\/jbc.M109357200","article-title":"Intestinal dipeptidyl peptidase IV is efficiently sorted to the apical membrane through the concerted action of N- and O-glycans as well as association with lipid microdomains","volume":"277","author":"Alfalah","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.09.011_bib44","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0960-9822(99)80263-2","article-title":"O-linked glycans mediate apical sorting of human intestinal sucrase-isomaltase through association with lipid rafts","volume":"9","author":"Alfalah","year":"1999","journal-title":"Curr. Biol. CB"},{"key":"10.1016\/j.biochi.2016.09.011_bib45","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1073\/pnas.74.5.2026","article-title":"Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts","volume":"74","author":"Kaplan","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2016.09.011_bib46","doi-asserted-by":"crossref","first-page":"11977","DOI":"10.1016\/S0021-9258(18)43217-6","article-title":"Lysosomal enzyme targeting. N-Acetylglucosaminylphosphotransferase selectively phosphorylates native lysosomal enzymes","volume":"256","author":"Reitman","year":"1981","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.09.011_bib47","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1016\/S0021-9258(19)69430-5","article-title":"UDP-N-acetylglucosamine:glycoprotein N-acetylglucosamine-1-phosphotransferase. Proposed enzyme for the phosphorylation of the high mannose oligosaccharide units of lysosomal enzymes","volume":"256","author":"Reitman","year":"1981","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.09.011_bib48","doi-asserted-by":"crossref","first-page":"8398","DOI":"10.1016\/S0021-9258(18)43507-7","article-title":"Identification of a rat liver alpha-N-acetylglucosaminyl phosphodiesterase capable of removing \u201cblocking\u201d alpha-N-acetylglucosamine residues from phosphorylated high mannose oligosaccharides of lysosomal enzymes","volume":"255","author":"Varki","year":"1980","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.09.011_bib49","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1016\/S0021-9258(19)69265-3","article-title":"Processing of the phosphorylated recognition marker in lysosomal enzymes. Characterization and partial purification of a microsomal alpha-N-acetylglucosaminyl phosphodiesterase","volume":"256","author":"Waheed","year":"1981","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.09.011_bib50","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1083\/jcb.103.4.1235","article-title":"Mannose-6-phosphate receptors for lysosomal enzymes cycle between the Golgi complex and endosomes","volume":"103","author":"Brown","year":"1986","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.biochi.2016.09.011_bib51","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1515\/BC.2002.206","article-title":"Processing and activation of lysosomal proteinases","volume":"383","author":"Ishidoh","year":"2002","journal-title":"Biol. Chem."},{"key":"10.1016\/j.biochi.2016.09.011_bib52","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.1073\/pnas.78.11.6967","article-title":"Morphologic study of the internalization of a lysosomal enzyme by the mannose 6-phosphate receptor in cultured Chinese hamster ovary cells","volume":"78","author":"Willingham","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2016.09.011_bib53","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1073\/pnas.80.3.775","article-title":"Identification and characterization of cells deficient in the mannose 6-phosphate receptor: evidence for an alternate pathway for lysosomal enzyme targeting","volume":"80","author":"Gabel","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2016.09.011_bib54","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0006-291X(82)91042-7","article-title":"Is there a mechanism for introducing acid hydrolases into liver lysosomes that is independent of mannose 6-phosphate recognition? Evidence from I-cell disease","volume":"105","author":"Owada","year":"1982","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2016.09.011_bib55","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(98)10034-X","article-title":"Broad screening test for sphingolipid-storage diseases","volume":"354","author":"Chen","year":"1999","journal-title":"Lancet (London, Engl."},{"key":"10.1016\/j.biochi.2016.09.011_bib56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/acs.molpharmaceut.5b00542","article-title":"A\u00a0comparative study on the alterations of endocytic pathways in multiple lysosomal storage disorders","volume":"2","author":"Rappaport","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biochi.2016.09.011_bib57","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/14084","article-title":"Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases","volume":"1","author":"Puri","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biochi.2016.09.011_bib58","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1172\/JCI0215420","article-title":"Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells","volume":"109","author":"Choudhury","year":"2002","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.biochi.2016.09.011_bib59","series-title":"Niemann-Pick Disease Type C: a Lipid Trafficking Disorder","author":"MC","year":"2001"},{"key":"10.1016\/j.biochi.2016.09.011_bib60","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/humu.20636","article-title":"NPC-db, a Niemann-Pick type C disease gene variation database","volume":"29","author":"Runz","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.biochi.2016.09.011_bib61","doi-asserted-by":"crossref","first-page":"24367","DOI":"10.1074\/jbc.M002184200","volume":"275","author":"Davies","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.09.011_bib62","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1016\/S0021-9258(18)45483-X","article-title":"Low density lipoprotein (LDL)-mediated suppression of cholesterol synthesis and LDL uptake is defective in Niemann-Pick type C fibroblasts","volume":"262","author":"Liscum","year":"1987","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.09.011_bib63","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0962-8924(00)01847-X","article-title":"Jamming the endosomal system: lipid rafts and lysosomal storage diseases","volume":"10","author":"Simons","year":"2000","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.biochi.2016.09.011_bib64","doi-asserted-by":"crossref","first-page":"26167","DOI":"10.1074\/jbc.M311591200","article-title":"Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport","volume":"279","author":"Vruchte","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.09.011_bib65","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/nm.1876","article-title":"Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium","volume":"14","author":"Lloyd-Evans","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.biochi.2016.09.011_bib66","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ymgme.2010.06.018","article-title":"Oxidative stress in Niemann-Pick disease, type C","volume":"101","author":"Fu","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.biochi.2016.09.011_bib67","doi-asserted-by":"crossref","first-page":"205713","DOI":"10.1155\/2012\/205713","article-title":"Oxidative stress: a pathogenic mechanism for Niemann-Pick type C disease","volume":"2012","author":"Vazquez","year":"2012","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.biochi.2016.09.011_bib68","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1091\/mbc.e04-05-0432","article-title":"Elevated endosomal cholesterol levels in Niemann-Pick cells inhibit rab4 and perturb membrane recycling","volume":"15","author":"Choudhury","year":"2004","journal-title":"Mol. Biol. cell"},{"key":"10.1016\/j.biochi.2016.09.011_bib69","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1074\/jbc.M109.037622","article-title":"Niemann-Pick C1 functions independently of Niemann-Pick C2 in the initial stage of retrograde transport of membrane-impermeable lysosomal cargo","volume":"285","author":"Goldman","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.09.011_bib70","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/hmg\/ddm100","article-title":"Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects","volume":"16","author":"Pacheco","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biochi.2016.09.011_bib71","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.celrep.2013.10.042","article-title":"Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease","volume":"5","author":"Sarkar","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.biochi.2016.09.011_bib72","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/302626","article-title":"Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype","volume":"65","author":"Millat","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biochi.2016.09.011_bib73","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1074\/jbc.M708735200","article-title":"Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding","volume":"283","author":"Gelsthorpe","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.09.011_bib74","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/8904_2011_49","article-title":"Treatment of human fibroblasts carrying NPC1 missense mutations with MG132 leads to an improvement of intracellular cholesterol trafficking","volume":"2","author":"Zampieri","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.biochi.2016.09.011_bib75","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1515\/BC.2009.077","article-title":"Impact of glycosylation and detergent-resistant membranes on the function of intestinal sucrase-isomaltase","volume":"390","author":"Wetzel","year":"2009","journal-title":"Biol. Chem."},{"key":"10.1016\/j.biochi.2016.09.011_bib76","doi-asserted-by":"crossref","DOI":"10.1007\/8904_2015_454","article-title":"The pathobiochemistry of gastrointestinal symptoms in a patient with niemann-pick type C disease","author":"Amiri","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.biochi.2016.09.011_bib77","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biochi.2016.09.011_bib78","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","article-title":"The molecular defect leading to Fabry disease: structure of human alpha-galactosidase","volume":"337","author":"Garman","year":"2004","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.biochi.2016.09.011_bib79","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.biochi.2016.09.011_bib80","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1010331404448","article-title":"Enzyme replacement and beyond","volume":"24","author":"Desnick","year":"2001","journal-title":"J.\u00a0Inherit. metabolic Dis."},{"key":"10.1016\/j.biochi.2016.09.011_bib81","doi-asserted-by":"crossref","DOI":"10.3402\/ecrj.v2.26721","article-title":"Fabry disease, respiratory symptoms, and airway limitation - a systematic review","volume":"2","author":"Svensson","year":"2015","journal-title":"Eur. Clin. Respir. J."},{"key":"10.1016\/j.biochi.2016.09.011_bib82","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2016.09.011_bib83","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cge.12673","article-title":"Gastrointestinal involvement in Fabry disease. So important, yet often neglected","volume":"89","author":"Politei","year":"2016","journal-title":"Clin. Genet."},{"key":"10.1016\/j.biochi.2016.09.011_bib84","first-page":"205","article-title":"The attenuated\/late onset lysosomal storage disorders: therapeutic goals and indications for enzyme replacement treatment in Gaucher and Fabry disease, Best practice & research","volume":"29","author":"Hollak","year":"2015","journal-title":"Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2016.09.011_bib85","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10545-010-9114-6","article-title":"A\u00a0modified lipid composition in Fabry disease leads to an intracellular block of the detergent-resistant membrane-associated dipeptidyl peptidase IV","volume":"33","author":"Maalouf","year":"2010","journal-title":"J.\u00a0Inherit. Metabolic Dis."},{"key":"10.1016\/j.biochi.2016.09.011_bib86","doi-asserted-by":"crossref","first-page":"e1003632","DOI":"10.1371\/journal.pgen.1003632","article-title":"Functional characterisation of alpha-galactosidase a mutations as a basis for a new classification system in fabry disease","volume":"9","author":"Lukas","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.biochi.2016.09.011_bib87","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"Jama"},{"key":"10.1016\/j.biochi.2016.09.011_bib88","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00431-003-1362-0","article-title":"Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements","volume":"163","author":"Grabowski","year":"2004","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.biochi.2016.09.011_bib89","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1126\/science.1589760","article-title":"Gaucher disease: new molecular approaches to diagnosis and treatment","volume":"256","author":"Beutler","year":"1992","journal-title":"Sci. (New York, N.Y.)"},{"key":"10.1016\/j.biochi.2016.09.011_bib90","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet (London, Engl."},{"key":"10.1016\/j.biochi.2016.09.011_bib91","first-page":"151","article-title":"Survey of hematological aspects of Gaucher disease","volume":"10","author":"Zimran","year":"2005","journal-title":"Hematol. Amst. Neth."},{"key":"10.1016\/j.biochi.2016.09.011_bib92","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1172\/JCI119437","article-title":"Identification and expression of acid beta-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients","volume":"99","author":"Grace","year":"1997","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.biochi.2016.09.011_bib93","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<407::AID-PATH377>3.0.CO;2-Z","article-title":"Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation)","volume":"188","author":"Zimmer","year":"1999","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.biochi.2016.09.011_bib94","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(01)05490-3","article-title":"Gaucher's disease","volume":"358","author":"Elstein","year":"2001","journal-title":"Lancet (London, Engl."},{"key":"10.1016\/j.biochi.2016.09.011_bib95","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.biocel.2005.05.008","article-title":"Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease","volume":"37","author":"Schmitz","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biochi.2016.09.011_bib96","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1432-1033.1987.tb11008.x","article-title":"Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts","volume":"164","author":"Jonsson","year":"1987","journal-title":"Eur. J. Biochem.\/FEBS"},{"key":"10.1016\/j.biochi.2016.09.011_bib97","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0955-0674(00)00233-7","article-title":"ER quality control: towards an understanding at the molecular level","volume":"13","author":"Ellgaard","year":"2001","journal-title":"Curr. Opin. cell Biol."},{"key":"10.1016\/j.biochi.2016.09.011_bib98","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1073\/pnas.0605928103","article-title":"The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms","volume":"103","author":"Steet","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2016.09.011_bib99","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1742-4658.2010.07588.x","article-title":"The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase","volume":"277","author":"Khanna","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.biochi.2016.09.011_bib100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K","article-title":"Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease","volume":"79","author":"Martiniuk","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.biochi.2016.09.011_bib101","series-title":"The Metabolic and Molecular Bases of Inherited Diseases","author":"H.R","year":"2001"},{"key":"10.1016\/j.biochi.2016.09.011_bib102","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jpeds.2004.01.053","article-title":"Pompe disease in infants and children","volume":"144","author":"Kishnani","year":"2004","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.biochi.2016.09.011_bib103","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1212\/01.WNL.0000165979.46537.56","article-title":"Disease severity in children and adults with Pompe disease related to age and disease duration","volume":"64","author":"Hagemans","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.biochi.2016.09.011_bib104","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ymgme.2010.06.003","article-title":"Pompe disease: dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three later-onset patients","volume":"101","author":"Bernstein","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.biochi.2016.09.011_bib105","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ymthe.2006.08.009","article-title":"Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease","volume":"14","author":"Fukuda","year":"2006","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.biochi.2016.09.011_bib106","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1566524024605789","article-title":"Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease)","volume":"2","author":"Raben","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.biochi.2016.09.011_bib107","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/humu.21121","article-title":"The pharmacological chaperone 1-deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha-glucosidase","volume":"30","author":"Flanagan","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.biochi.2016.09.011_bib108","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrm1052","article-title":"Quality control in the endoplasmic reticulum","volume":"4","author":"Ellgaard","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biochi.2016.09.011_bib109","doi-asserted-by":"crossref","first-page":"e102092","DOI":"10.1371\/journal.pone.0102092","article-title":"The pharmacological chaperone AT2220 increases the specific activity and lysosomal delivery of mutant acid alpha-glucosidase, and promotes glycogen reduction in a transgenic mouse model of Pompe disease","volume":"9","author":"Khanna","year":"2014","journal-title":"PloS One"},{"issue":"Pt 3","key":"10.1016\/j.biochi.2016.09.011_bib110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1042\/bj2890687","article-title":"The conservative substitution Asp-645-->Glu in lysosomal alpha-glucosidase affects transport and phosphorylation of the enzyme in an adult patient with glycogen-storage disease type II","volume":"289","author":"Hermans","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.biochi.2016.09.011_bib111","first-page":"457","article-title":"Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals","volume":"13","author":"Wang","year":"2011","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"10.1016\/j.biochi.2016.09.011_bib112","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCGENETICS.113.000249","article-title":"Gene mutations versus clinically relevant phenotypes: lyso-Gb3 defines Fabry disease","volume":"7","author":"Niemann","year":"2014","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.biochi.2016.09.011_bib113","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1194\/jlr.M061978","article-title":"Evaluation of plasma cholestane-3beta,5alpha,6beta-triol and 7-ketocholesterol in inherited disorders related to cholesterol","volume":"57","author":"Boenzi","year":"2016","journal-title":"Metab. J. Lipid Res."},{"key":"10.1016\/j.biochi.2016.09.011_bib114","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13023-015-0274-1","article-title":"A\u00a0novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease","volume":"10","author":"Giese","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.biochi.2016.09.011_bib115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"Grabowski","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.biochi.2016.09.011_bib116","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymgme.2009.08.003","article-title":"Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants","volume":"99","author":"Kishnani","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.biochi.2016.09.011_bib117","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ymgme.2010.08.009","article-title":"High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa","volume":"101","author":"de Vries","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.biochi.2016.09.011_bib118","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/mt.2014.224","article-title":"Enzyme enhancers for the treatment of Fabry and Pompe disease","volume":"23","author":"Lukas","year":"2015","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.biochi.2016.09.011_bib119","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1358\/dot.2006.42.1.937457","article-title":"Miglustat: substrate reduction therapy for glycosphingolipid lysosomal storage disorders","volume":"42","author":"Lachmann","year":"2006","journal-title":"Drugs Today (Barcelona, Spain 1998)"},{"key":"10.1016\/j.biochi.2016.09.011_bib120","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF00219337","article-title":"Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease","volume":"88","author":"Leinekugel","year":"1992","journal-title":"Hum. Genet."},{"key":"10.1016\/j.biochi.2016.09.011_bib121","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","article-title":"Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor","volume":"5","author":"Fan","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.biochi.2016.09.011_bib122","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1046\/j.1432-1327.2000.01457.x","article-title":"In\u00a0vitro inhibition and intracellular enhancement of lysosomal alpha-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives","volume":"267","author":"Asano","year":"2000","journal-title":"Eur. J. Biochem.\/FEBS"},{"key":"10.1016\/j.biochi.2016.09.011_bib123","series-title":"Amicus Therapeutics Announces European Commission Approval for Galafold\u2122 (Migalastat) in Patients with Fabry Disease in European Union","author":"Amicus Therapeutics","year":"2016"},{"key":"10.1016\/j.biochi.2016.09.011_bib124","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1074\/jbc.M111.280016","article-title":"Ex\u00a0vivo and in\u00a0vivo effects of isofagomine on acid beta-glucosidase variants and substrate levels in Gaucher disease","volume":"287","author":"Sun","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.09.011_bib125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bcmd.2013.03.006","article-title":"Transgenic mice expressing human glucocerebrosidase variants: utility for the study of Gaucher disease","volume":"51","author":"Sanders","year":"2013","journal-title":"Blood Cells, Mol. Dis."},{"key":"10.1016\/j.biochi.2016.09.011_bib126","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.mt.6300074","article-title":"Pharmacological enhancement of mutated alpha-glucosidase activity in fibroblasts from patients with Pompe disease","volume":"15","author":"Parenti","year":"2007","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.biochi.2016.09.011_bib127","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1750-1172-7-91","article-title":"Safety and pharmacodynamic effects of a pharmacological chaperone on alpha-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies","volume":"7","author":"Germain","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.biochi.2016.09.011_bib128","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/humu.21530","article-title":"A\u00a0pharmacogenetic approach to identify mutant forms of alpha-galactosidase A that respond to a pharmacological chaperone for Fabry disease","volume":"32","author":"Wu","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.biochi.2016.09.011_bib129","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ymgme.2013.01.009","article-title":"A\u00a0Phase 2 study of migalastat hydrochloride in females with Fabry disease: selection of population, safety and pharmacodynamic effects","volume":"109","author":"Giugliani","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.biochi.2016.09.011_bib130","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/mt.2015.62","article-title":"Pharmacological chaperone therapy: preclinical development, clinical translation, and prospects for the treatment of lysosomal storage disorders","volume":"23","author":"Parenti","year":"2015","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.biochi.2016.09.011_bib131","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nm1021","article-title":"Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice","volume":"10","author":"Kieran","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.biochi.2016.09.011_bib132","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/mt.2009.53","article-title":"The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts","volume":"17","author":"Porto","year":"2009","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.biochi.2016.09.011_bib133","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/mt.2011.271","article-title":"Co-administration with the pharmacological chaperone AT1001 increases recombinant human alpha-galactosidase A tissue uptake and improves substrate reduction in Fabry mice","volume":"20","author":"Benjamin","year":"2012","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.biochi.2016.09.011_bib134","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.bbrc.2008.02.125","article-title":"Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase","volume":"369","author":"Shen","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2016.09.011_bib135","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJMoa032613","article-title":"Cord-blood transplants from unrelated donors in patients with Hurler's syndrome","volume":"350","author":"Staba","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.biochi.2016.09.011_bib136","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.biochi.2016.09.011_bib137","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ymgme.2012.11.006","article-title":"Developmental outcome post allogenic bone marrow transplant for Niemann Pick Type C2","volume":"108","author":"Breen","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.biochi.2016.09.011_bib138","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1172\/JCI28873","article-title":"Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice","volume":"116","author":"Biffi","year":"2006","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.biochi.2016.09.011_bib139","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1172\/JCI200419205","article-title":"Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells","volume":"113","author":"Biffi","year":"2004","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.biochi.2016.09.011_bib140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In\u00a0vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Sci. (New York, N.Y.)"},{"key":"10.1016\/j.biochi.2016.09.011_bib141","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Sci. (New York, N.Y.)"},{"key":"10.1016\/j.biochi.2016.09.011_bib142","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1872214808666140115111350","article-title":"Treatment of lysosomal storage diseases: recent patents and future strategies","volume":"8","author":"Ortolano","year":"2014","journal-title":"Recent Pat. Endocr. Metabolic Immune Drug Discov."},{"key":"10.1016\/j.biochi.2016.09.011_bib143","doi-asserted-by":"crossref","first-page":"816593","DOI":"10.1155\/2015\/816593","article-title":"Recent advances in the diagnosis and treatment of niemann-pick disease type C in children: a guide to early diagnosis for the general pediatrician","volume":"2015","author":"Alobaidy","year":"2015","journal-title":"Int. J. Pediatr."},{"key":"10.1016\/j.biochi.2016.09.011_bib144","doi-asserted-by":"crossref","first-page":"276ra226","DOI":"10.1126\/scitranslmed.3010101","article-title":"Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease","volume":"7","author":"Vite","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biochi.2016.09.011_bib145","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/1440-1681.12285","article-title":"Systemic administration of 2-hydroxypropyl-beta-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function","volume":"41","author":"Lopez","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908416301900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908416301900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T18:27:24Z","timestamp":1657304844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908416301900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":145,"alternative-id":["S0300908416301900"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2016.09.011","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726770239.793542543","asserted-by":"object"}]},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations in membrane trafficking and pathophysiological implications in lysosomal storage disorders","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2016.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights reserved.","name":"copyright","label":"Copyright"}]}}